According to recent research, increased Gal-3 levels after ICU admission predicted S-AKI and death in sepsis patients, but Gal-3 inhibition in a CLP rat model dramatically decreased S-AKI and mortality. The gene discussed is LGALS3; the disease is Sepsis.